← All Volitionrx LTD filings

Volitionrx LTD DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

AMEX
VNRX
Volitionrx LTD
DEF: VolitionRx Schedules 2026 Annual Meeting, Proposes Share Reduction
VolitionRx Limited announced its 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026, and proposed a significant reduction in authorized shares.
AMEX
VNRX
Volitionrx LTD
DEF: VolitionRx Seeks Shareholder Nod for Dilution, Reverse Split
VolitionRx Limited calls a special meeting to approve significant share issuance to Lind Global Asset Management and a potential reverse stock split to address listing compliance and marketability.
AMEX
VNRX
Volitionrx LTD
DEF: VolitionRx Seeks Stockholder Approval for Increased Authorized Shares at 2025 Annual Meeting
VolitionRx Limited is holding its 2025 Annual Meeting of Stockholders on June 18, 2025, to vote on key proposals including the election of directors and an increase in authorized shares.
AMEX
VNRX
Volitionrx LTD
DEF 14A: VolitionRx Seeks Stockholder Approval for Director Elections, Auditor Ratification, Executive Pay, and Incentive Plan
VolitionRx is holding its annual meeting to elect directors, ratify the auditor, approve executive compensation, increase authorized shares, and approve a new stock incentive plan.